发明名称 Lactone integrin antagonists
摘要 The present invention relates to a class of compounds represented by the Formula I. or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the alphavbeta3 and/or the alphavbeta5 integrin.
申请公布号 US2004116472(A1) 申请公布日期 2004.06.17
申请号 US20030717238 申请日期 2003.11.19
申请人 PHARMACIA CORPORATION 发明人 RUMINISKI PETER;PENNING THOMAS D.;JIANG LAN;DEVADAS BALEKUDRU;ROGERS THOMAS;VANCAMP JENNIFER;YUAN CHESTER
分类号 C07D307/33;A61K31/365;A61K31/506;A61P1/02;A61P3/14;A61P9/00;A61P9/10;A61P19/02;A61P19/10;A61P21/00;A61P27/02;A61P31/12;A61P35/00;A61P35/04;A61P43/00;C07D309/30;C07D405/12;C07D405/14;(IPC1-7):A61K31/443;A61K31/366;C0745/02 主分类号 C07D307/33
代理机构 代理人
主权项
地址